Financial News
All News about Amneal Pharmaceuticals Inc
Amneal to Report First Quarter 2022 Results on May 4, 2022
April 07, 2022
Via Business Wire
Via Benzinga
Amneal Expands Injectables Portfolio with 4 New Products
February 17, 2022
Via Business Wire
Via Business Wire
Amneal Acquires Saol Therapeutics’ Baclofen Franchise
January 05, 2022
Via Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
December 17, 2021
Via Benzinga
TherapeuticsMD, Amneal Settle US Patent Litigation For Bijuva
December 08, 2021
Via Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Amneal Receives Approval for Difluprednate Ophthalmic Emulsion
November 19, 2021
Via Business Wire
Amneal to Virtually Participate at Upcoming Investor Conferences
November 12, 2021
Via Business Wire
Amneal Pharmaceuticals, inc (AMRX) Q3 2021 Earnings Call Transcript
November 03, 2021
Via The Motley Fool
Topics
Earnings
Exposures
Financial
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.